ArticleRheumatology (Oxford, England)2010
Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics.
Article in Rheumatology (Oxford, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 147 citations in OpenAlex.
- Trial
- Article
- Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study.RMD open · 2025Article
- Emerging patterns in nanoparticle-based therapeutic approaches for rheumatoid arthritis: A comprehensive bibliometric and visual analysis spanning two decades.Open life sciences · 2025Article
- Article
- High risk of stroke in ANCA-associated vasculitis-a population-based study.Rheumatology (Oxford, England) · 2023Article
- The prevalence of rheumatoid arthritis in Western Australia.BMC rheumatology · 2022Article
- Global epidemiology of rheumatoid arthritis.Nature reviews. Rheumatology · 2022Review
- Lebanese Hospital-Based Rheumatoid Arthritis Registry: Characteristics of Patients and Comparison with Other Populations.Mediterranean journal of rheumatology · 2022Article
- Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond.Frontiers in oncology · 2022Review
- The prevalence of rheumatoid arthritis in Spain.Scientific reports · 2020Article
- Is Axial Spondyloarthritis More Common Than Rheumatoid Arthritis?Current rheumatology reports · 2020Review
- Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system.Rheumatology international · 2019Article
- Discussions of lifestyle habits as an integral part of care management: a cross-sectional cohort study in patients with established rheumatoid arthritis in Sweden.Rheumatology advances in practice · 2019Article
- Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study.Archives of medical science : AMS · 2019Article
- Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study.BMJ open · 2018Article
- Prevalence of chronic widespread pain in a population-based cohort of patients with spondyloarthritis - a cross-sectional study.BMC rheumatology · 2018Article
- Factors associated with hand joint destruction in Chinese patients with rheumatoid arthritis.BMC musculoskeletal disorders · 2017Article
- Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.BMC musculoskeletal disorders · 2016Article
- Incidence and prevalence of gout in Western Sweden.Arthritis research & therapy · 2016Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo gain updated estimates of prevalence and incidence of RA and proportion on biological treatment in southern Sweden.
methodsInpatient and outpatient health care provided to residents in the southernmost county of Sweden (1.2 million inhabitants) is registered in the Skåne Health Care Register (SHCR). We identified residents aged > or = 20 years who had received a diagnosis of RA at least twice during 2003-08. Valid point prevalence estimates by 31 December 2008 were obtained by linkage to the Swedish population register, and information on biological treatment was obtained from the South Swedish Arthritis Treatment Group register. We also tested our estimates of RA occurrence in a series of sensitivity analyses to investigate the effect of altered case criteria and the uncertainty generated by clinical visits without diagnoses.
resultsThe prevalence of RA in adults was estimated to 0.66% (women = 0.94%, men = 0.37%). The prevalence peaked at age 70-79 years (women = 2.1%, men = 1.1%) before dropping in those aged > or = 80 years. Of prevalent cases, 20% had ongoing biological treatment, a percentage that was highest in women aged 40-49 years (36%). The incidence of RA in 2008 was estimated as 50/100,000 (women = 68/100,000, men = 32/100,000).
conclusionsWhen compared with a previous report from southern Sweden, the prevalence of RA seems not to have declined in the last decade. The proportion of patients with ongoing biological treatment was slightly higher in women than men. SHCR data are promising additions to other methods to gain frequency estimates of clinically important disease in a timely and cost-efficient manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.